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Abstract The adeno-associated virus (AAV) encoded Rep78 is 
a multifunctional protein which is able to regulate transcription, 
is required for AAV DNA replication, and appears necessary for 
site specific integration of AAV DNA into human chromosome 
19. Being analogous to the large T antigen, the replication 
protein of polyomaviruses which is known to homo-multimerize, 
it seemed likely that the Rep78 protein would also interact with 
itself to carry out at least some of its functions. Furthermore, in 
electrophoretic mobility shift assay studies by many laboratories 
on Rep78/68 protein interaction with AAV terminal repeat DNA 
it has been noticed that multiple high bands often result. These 
data suggest Rep78-Rep78 interaction. In this study it is directly 
demonstrated that Rep78 is able to form multimeric complexes 
as measured by West-Western and chemical cross-linking assays. 
Furthermore, using an amino-truncated Rep78 protein, it is 
demonstrated that the Rep78 homo-multimerization domain is 
contained within the carboxy-half of the protein. 
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1. Introduction 
Adeno-associated virus (AAV) is a helper dependent human 
parvovirus, which requires that the cell be co-infected with an 
adeno- or herpes virus to allow for AAV productive infection 
[1,2]. The Rep78 nuclear protein, encoded by AAV, plays 
important roles in AAV DNA replication [3,4], AAV chromo-
somal DNA integration into human chromosome 19 [5,6], the 
irans-regulation of AAV gene expression [7-9], and the /rani-
regulation of various heterologous genes [10-15]. Consistent 
with Rep78's many biological roles it has many defined bio-
chemical activities. Rep78 is able to recognize secondary 
structure within DNA (AAV's terminal repeats, TR), bind 
DNA of a specific sequence (GCTC3), has site specific and 
strand specific endonuclease activity (nicks AAV DNA at the 
terminal resolution site [trs] within the TR, binds ATP, and 
possesses an ATP dependent DNA helicase activity [16-20]. 
The basis for this study was the likelihood that homo-multi-
merization of Rep78 was needed for at least some of Rep78's 
numerous functions. It is known that the large T antigen, the 
analogous nuclear replication protein of polyomaviruses, has 
many of the same functions as Rep78 [21]. Large T antigen is 
known to form a double hexamer while binding to the origin 
of SV40 DNA replication [22]. This resulting complex then 
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has helicase activity which is needed for the initiation of SV40 
DNA replication. Large T antigen also binds p53 as a dimer 
[23]. 
The finding that in electrophoretic mobility shift assays of 
Rep78, and the closely related Rep68 protein, interaction with 
AAV's TRs results in multiple bands has initiated the hypoth-
esis of Rep-Rep protein interaction to form multimers [24]. 
However, these results are only suggestive and do not directly 
demonstrate that direct Rep78-Rep78 interactions are taking 
place. Here, Rep78-Rep78 recognition is directly demon-
strated using two different assay systems, West-Western and 
chemical cross-linking analysis. Furthermore, the Rep78-
Rep78 homo-multimerization interaction domain is mapped 
to be enclosed within the carboxy-half of the molecule. 
2. Materials and methods 
2.1. Production and purification of K S-labeled MBP and MBP-Rep78 
Rep78 was generated as a fusion protein with maltose binding 
protein (MBP) using the New England BioLabs protein fusion and 
purification kit according to the manufacturer's instructions. A de-
tailed protocol for the construction of the pMal-Rep78 and purifica-
tion of MBP-Rep78 protein is given elsewhere [20]. For the prepara-
tion of 35S-labeled MBP-Rep78 chimeric protein essentially the same 
protocol is used with minor modifications. Briefly, overnight cultures 
were inoculated again in 10 ml of LB medium, and grown until the 
absorbance reached A60o 0.5. The cells were pelleted and resuspended 
in minimal medium previously warmed to 37°C. After approximately 
10 min growth in minimal medium, 100 μ θ of [35S]methionine, 50 μΐ 
of 2 mM methionine free amino acid mix (Promega), and IPTG were 
added to a final concentration of 0.3 mM. Incubation was continued 
for 30 min with agitation at 37°C, then unlabeled methionine was 
added to a final concentration of 1 mM and 2 ml of Luria broth. 
Cells were pelleted, resuspended in column buffer (25 mM Tris, pH 
7.5, 200 mM NaCl, 1 mM DTT, and 1 mM EDTA) and stored at 
—70°C for 30 min. Purification of induced chimeric protein in labeled 
medium was essentially carried out as mentioned elsewhere [25]. 
2.2. Cloning and purification of His-Rep78 
Rep78 open reading frame from pALTER-AAV-3 [20], on a 1.9 kb 
Sphl and Xhol fragment, was cloned in-frame with the 6 histidine tag 
sequence into an altered pQE-32 expression vector (Qiagen Inc.). The 
polylinker of the original vector was first replaced with a custom 
polylinker containing Sphl and Xhol sites. The resulting construct, 
pQE-Rep78, produced His-Rep78 protein upon IPTG induction and 
was purified to 90% homogeneity according to the manufacturer's 
instructions. 
2.3. Construction of amino-truncated Rep78 mutants 
Two Rep78 mutants with N-terminal deletions were generated by 
digesting the pMal-Rep vector [20] with Xhol and either EcoRI or 
BamHI. The full length Rep open reading frame is at nucleotides (nt) 
321-2185. The BamHI site is at nt 1045 and the EcoRI site is at nt 
1985. The Xhol site is downstream of the Rep ORF at nt 2233. After 
digesting the plasmid pMal-Rep with either BamHl+Xhol or EcoR-
I+Xhol, N-terminal deleted fragments were isolated and these were 
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again cloned into the pMalc2 expression vector (New England Bio-
Labs), in frame with MBP. These vectors, upon IPTG induction, 
produced recombinant mutant MBP-chimeric proteins. 
2.4. West-Western analysis 
Electrophoretically separated proteins were electroblotted onto ni-
trocellulose as described by Towbin et al. [25]. Additional protein 
binding sites on the nitrocellulose were blocked by incubating for 30 
min at room temperature in 1% protease free BSA prepared in bind-
ing buffer (25 mM Tris pH 7.8, 100 mM NaCl, 5 mM MgCl2, 1 mM 
dithiothreitol (DTT), 1 mM EDTA, 5 mM KC1). All the additional 
steps of washing and incubation were performed in 0.1% protease free 
BSA prepared in binding buffer. For West-Western blot analysis, the 
blots were incubated for 30 min at room temperature with constant 
rocking in 1:10 000 anti-MBP (New England BioLabs) antibodies, or 
1:200 dilution of anti-Rep antibodies (a generous gift from Dr. James 
Trempe) raised in rabbit. Again the blots were subjected to three 
washes of 10 min each with constant stirring. Incubation with 
1:10000 dilution of anti-rabbit antibodies conjugated to horseradish 
peroxidase (HRPO) was carried out for 30 min at room temperature 
with rocking. After extensive washing, blots were incubated in perox-
idase enzymatic assay solution consisting of 5 mg of 4-chloronaphthol 
substrate and 10 μΐ of H2O2. After the appearance of the bands the 
blot was thoroughly rinsed with water and dried. For chemilumines-
cence assays, after the incubation of the blots with HRPO conjugated 
anti-rabbit antibodies, the blots were extensively washed and incu-
bated in Luminol substrate solution with enhancer (Renaisense, Du-
Pont) for 1 min. Dried filters were exposed to films for varying lengths 
of time to get appropriate signal. For West-Western analysis, after the 
BSA blocking step, filters were incubated either in 35S-labeled MBP or 
in 35S-labeled MBP-Rep78 for 30 min prepared in 1% protease free 
BSA in binding buffer with constant rocking. Then the filters were 
given a single wash in binding buffer, dried and autoradiographed. 
West-Western analyses were also performed with either unlabeled 
MBP (10 Hg/ml) or unlabeled MBP-Rep78 (10 μ^piύ). It is similar 
to the Western analysis except for the incubation of the cold protein 
before probing with antibodies. Rep78 binding proteins on the blots 
were visualized by HRPO enzymatic assays as was done in the case of 
Western blot analysis. 
2.5. Protein-protein cross-linking with dithiobis 
sulfosuccinimidylpropionate (DTSSP) 
In a final volume of 50 μΐ (PBS, 20 mM sodium phosphate buffer, 
0.15 M NaCl, pH 7.5), 5 μg of Rep78 was incubated with different 
concentrations of DTSSP ranging from 0.2 to 6.4 mM for 30 min at 
room temperature. The reaction was terminated by the addition of an 
equal volume of 1 M Tris pH 7.5 and the products were separated on 
8% SDS-PAGE. Gels were stained with Coomassie brilliant blue. 
raphy using MBP-Rep78 fusion protein bound to amylose resin. 
Amylose resin, 0.5 ml (New England BioLabs) extensively washed 
in binding buffer (0.25 mM Tris pH 7.8, 1 mM DTT, 1 mM 
PMSF, 1 mM EDTA, 150 mM NaCl, 5 mM MgCl2, 5 mM KC1), 
was incubated with 5 μg of MBP-Rep78 fusion protein at room tem-
perature for 30 min with constant stirring, and loaded onto a column. 
The Rep78-resin was extensively washed and then 10 μg of 35S-labeled 
HeLa cell nuclear extract was incubated with the MBP-Rep78/amy-
lose resin in 1 ml binding buffer. After extensive washing, bound 
proteins were eluted along with MBP-Rep78 with 10 mM maltose 
in binding buffer. These proteins were subjected to 10% SDS-
PAGE, and the gels were dried and autoradiographed. 
3. Results 
3.1. Rep78 binds to itself as determined by West-Western 
analysis 
Many transcriptional factors have the ability to form di-
mers and higher order complexes. In some cases multimeric 
complexes are required for biological activity, such as the E2 
transactivator protein of the papillomaviruses [27]. The possi-
bility of Rep78 interacting with itself was tested by two direct 
methods. First, Rep78-Rep78 interaction was explored using 
West-Western analysis. MBP-Rep78 was electrophoretically 
separated, blotted onto nitrocellulose membranes and probed 
with purified [35S]MBP-Rep78 probe. As shown in Fig. 1A 
there was a dosage dependent increase in the binding to 
Rep78. This interaction was not observed when the membrane 
was probed with labeled MBP (data not shown). Next, in Fig. 
IB, similar blots were also subjected to a chemiluminescence 
assay to document dosage dependent Rep-Rep interactions. 
However, in this case the target protein was SDS-PAGE/ 
blotted His-Rep78. His-Rep78 was produced by cloning the 
Rep78 ORF into the pQE-32 vector and purified from bacter-
ia as described in Section 2. The blots were then incubated 
2.6. Generation of 35 S-labeled nuclear extracts 
Generation of 35 S-labeled nuclear cellular extracts from HeLa cells 
was carried out as described by Owens et al. [26], with the following 
alterations. Briefly, HeLa cells were grown to 80% confluence in 100 
mm plates in the presence of 7% fetal calf serum and were infected 
with adenovirus type 2 (multiplicity of infection (MOI) of 5) and 
AAV (MOI of 5) when appropriate. Medium was aspirated, the cells 
washed twice with methionine free medium and incubated in the same 
for 4 h in a CO2 incubator in the presence of 200 \lCi of 
[35S]methionine. Cells were washed thrice in PBS and incubated in 
the same buffer for 30 min in the presence of 1 mM EDTA. Cells 
were scraped off in 2 ml of PBS, centrifuged, and resuspended in 1 ml 
of buffer containing 0.25 M sucrose, 10 mM Tris-HCl, 10 mM MgCl2, 
0.5% Nonidet P40, 1.0 mM phenylmethylsulfonyl fluoride (PMSF), 
and 1.0 mM DTT. After 10 min of incubation the cells were sheared 
with six strokes of a Dounce homogenizer using pestle B. The nuclei 
were then pelleted by centrifugation for 5 min at 1800Xg and resus-
pended in 300 μΐ of 50 mM HEPES-KOH (pH 7.5), 1 mM PMSF, 
and 0.5 mM DTT, frozen at —70°C, thawed on ice and adjusted to 
600 mM NaCl. After 1 h on ice the debris were pelleted by centrifu-
gation at 20000Xg for 1 h. Finally, glycerol was added to 20% and 
the nuclear extracts frozen at — 70°C. 
2.7. Rep78 affinity chromatography 
Selection of Rep78 binding cellular proteins from the HeLa cell 35S-
labeled nuclear extracts was carried out by Rep78 affinity chromatog-
Fig. 1. Rep78 binds to itself as determined by West-Western analy-
sis. A: Increasing concentrations of MBP-Rep78 was applied onto 
8% SDS-PAGE and the separated protein was blotted onto nitrocel-
lulose paper. After probing with labeled MBP-Rep78, blots were 
autoradiographed. B: Increasing concentrations of His-Rep78 were 
electrophoretically separated on 8% SDS-PAGE and blotted onto 
nitrocellulose paper. Chemiluminescence assay was conducted with 
MBP antibodies after incubation with MBP-Rep78. 
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Fig. 2. Production of purified MBP-Rep78 and His-Rep78 chimeric 
proteins. The Rep78 open reading frame was cloned into the 
pMalc2 vector to produce MBP-Rep78 protein upon induction 
(New England Biolabs Protein Purification System) and purified per 
kit instructions. The Rep78 open reading frame was also cloned 
into pQE-31 to produce his-Rep78 upon induction (Qiagen) and 
purified per kit instructions. The purified chimeric proteins were 
analyzed on 8% SDS-PAGE, gels were dried and Commassie blue 
stained. The lanes were loaded as indicated. The lane indicated 
as 'total induced' refers to total protein from the his-Rep78 induced 
E. coli. 
with MBP-Rep78 and probed with anti-MBP antibodies. Ex-
amples of bacterially produced and purified MBP-Rep78 and 
His-Rep78 are shown in Fig. 2. Without Rep78-Rep78 inter-
action, chimeric MBP-Rep78 probe could not bind the His-
Rep78 target. These data indicate direct interaction, homo-
multimerization, between Rep78 proteins. 
Fig. 4. Production and purification of wild type and N-terminal de-
leted mutant recombinant MBP-Rep chimeric proteins. Cloned mu-
tant proteins were expressed in E. coli and purified by affinity chro-
matography on amylose resin as mentioned in Section 2. Purified 
proteins were subjected to 10% SDS-electrophoresis and stained 
with Coomassie brilliant blue. The marker lane includes 6 promi-
nent proteins with molecular weights of 97.4, 66.2, 55, 42.7, 40, 21.5 
and 14 kDa. Low molecular weight bands in both Bam-Rep and 
wild type Rep (MBP-Rep78) are favored degradation products of 
the full length recombinant proteins. 
3.2. Rep78 binds itself to form multimeric complexes as 
determined by chemical cross-linking analysis 
Rep78-Rep78 interaction was also investigated by chemical 
cross-linking. Cross-linking experiments were performed with 
DTSSP which is a homo-bifunctional reversible cross-linking 
reagent. As shown in Fig. 3, [35S]MBP-Rep78 was cross-
linked with itself by this reagent as shown by the appearance 
of new high bands. With the increasing concentrations of 
DTSSP, increasingly intense higher order complexes were ob-
served. This covalent cross-linking is possible when the mole-
cules interact with each other in solution to allow the homo-
bifunctional DTSSP agent to carry out covalent cross-linking. 
These data further indicate that Rep78 interacts with itself 
and forms higher order complexes. Due to the large sizes of 
these complexes accurate measurements of their apparent mo-
lecular weights are not possible, and thus the number of 
MBP-Rep78 molecules in these complexes cannot be accu-
rately determined. Furthermore, breakdown products of full 
length MBP-Rep78 may still be able to homo-multimerize, 
further complicating the analysis. 
Fig. 3. Rep78 forms multimeric complexes as determined by chemi-
cal cross-linking. Chemical cross-linking of MBP-Rep78 with 
DTSSP. Rep-78 (5 mg/ml) was incubated in 20 mM sodium phos-
phate buffer, 0.15 M NaCl, pH 7.5 (PBS) along with different con-
centrations of DTSSP as indicated. Reaction was terminated with 
an equal volume of 1 M Tris, pH 7.5 and applied onto 8% SDS-
PAGE. Arrows indicate the formation of higher order complexes 
(dimer, trimer, etc.) of MBP-Rep78. As a favored degradation prod-
uct of MBP-Rep78 is also present in the reaction, some of the 
crosslink-generated products bands may include these species, thus 
complicating the interpretation of these data. 
3.3. The Rep78-Rep78 interaction domain maps to the 
carboxy-half of the molecule 
To map the homo-multimerization domain(s) of Rep78 two 
amino-terminal deleted versions of Rep78 were constructed. 
Bam-Rep (deleted to the BamUl site at nt 1045) deletes the 
241 amino-terminal amino acids, while Eco-Rep (deleted to 
the EcoRl site at nt 1985) deletes to amino acid 554. These 
truncated Rep78 versions were cloned into the same expres-
sion vector which produced MBP-Rep78 fusion protein. The 
truncated proteins were induced, 35S-labeled, and purified, as 
shown in Fig. 4. These truncated Rep probes were then com-
pared to full length MBP-Rep78 in West-Western assays for 
binding to membrane bound MBP-Rep78. As shown in Fig. 5, 
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three equivalent membranes were each probed with a different 
probe. Note that the Bam-Rep probe was able to recognize 
and bind MBP-Rep78, while the Eco-Rep probe was not. 
These data strongly suggest that the carboxy-half of Rep78 
contained the homo-multimerization domain, and that the 
terminal 66 amino acids were insufficient for Rep78-Rep78 
binding. 
3.4. The Rep78 protein binds to specific nuclear proteins 
present in adenovirus and AA V infected cells by 
Rep78 affinity chromatography 
Rep78 is a nuclear protein, thus we next observed if Rep78 
was able to recognize nuclear proteins specifically present in 
AAV plus adenovirus infected cells. The binding of Rep78 to 
adenovirus and AAV specific cellular proteins was assayed by 
Rep78 affinity chromatography. A chromatography column 
with bound Rep78 was first generated by incubating MBP-
Rep78 protein in an amylose resin column as described in 
Section 2. In vivo 35S-labeled HeLa cellular extracts were 
passed through the column, the column washed, and then 
bound protein eluted with 10 mM maltose and 100 mM 
NaCl and analyzed by 10% SDS-PAGE. The results are 
shown in Fig. 6. As seen in this figure there are multiple 
new proteins which are selected by binding Rep78 in the 
Rep78 selected HeLa+Ad+AAV lane as compared to the 
Rep78 selected HeLa+Ad lane. One new AAV specific pro-
tein, labeled #1 in Fig. 6, is of a size consistent with Rep78 
(78 kDa). Another Rep78 selected protein, labeled #2 in Fig. 
6, is of a size consistent with the major capsid protein VP3 (61 
kDa). The faint band(s) present above the putative Rep78 
band (#1) may be the minor capsid VP1 (87 kDa). Fig. 6. Rep78 binds multiple AAV specific nuclear proteins in ade-
novirus and AAV infected cells. HeLa cells were labeled with 
[35S]methionine and nuclear extracts made. These nuclear extract 
were then selected by Rep78 affinity using amylose resin. The se-
lected proteins were then analyzed by 8% SDS-PAGE, along with 
samples of total nuclear protein, and then autoradiographed. Only 
the top half of the autoradiograph is shown to allow greater detail. 
No obvious differences were observed between the two selected pro-
tein populations in the bottom half of the gel. Notice that multiple 
new proteins are selected in the HeLa+Ad+AAV lanes as compared 
to the HeLa+Ad lane. The new AAV specific protein labeled #1 is 
of a size consistent with Rep78 (78 kDa), while the protein labeled 
#2 is of a size consistent with the major capsid protein VP3 (61 
kDa). The faint band(s) present above the putative Rep78 band 
(#1) may be the minor capsid VP1 (87 kDa). 
4. Discussion 
Fig. 5. The Rep78-Rep78 interaction domain is fully included within 
the carboxy-half of Rep78. West-Western analysis of MBP-Rep78 
electrophoretically separated, electroblotted, and probed with one of 
three 35S-labeled Rep probes (wild type MBP-Rep78, Bam-Rep, and 
Eco-Rep mutant protein probes). Note that both the wild type 
MBP-Rep78 and Bam-Rep probes were able to recognize membrane 
bound MBP-Rep78, while Eco-Rep was not. The low mobility band 
below MBP-Rep78 is a degradation product of the full length pro-
tein. 
This study directly demonstrates that AAV Rep78 forms 
homo-multimers by both West-Western and chemical cross-
linking analysis. We believe that this self recognition is to be 
expected due to Rep78's multiple roles in transcriptional reg-
ulation [7-15] and DNA replication [3,4]. Rep78's interaction 
with DNA has been studied extensively [6,16,17,28-32], but its 
potential protein-protein interactions have not. Thus far the 
Rep78 protein has been shown to bind the AAV capsid pro-
teins [33] and to the cellular transcription factor Spl [13]. We 
had several reasons to suspect that Rep78 is able to form 
homo-multimers. First, it is known that some cellular and 
viral transcription factors form homo-multimers, such as pa-
pillomavirus E2, which then have a biological activity [27,34]. 
Second, Rep78 is highly analogous to large T antigen, the 
equivalent replication protein of the polyomaviruses. Large 
T antigen has many of the same functions as Rep78 and is 
known to form multimeric complexes [21-23]. Finally, obser-
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vations that electrophoretic mobility shift assays (EMSA) of 
Rep68 and Rep78 protein interaction with AAV's T R D N A 
results in multiple bands suggested Rep-Rep protein interac-
tion [26]. However, these latter results are only suggestive of 
Rep-Rep protein interaction and do not directly demonstrate 
that such interactions are taking place. Such multiple banding 
in the E M S A assays could be caused by induction of alter-
native D N A secondary structure due to Rep78 binding, or 
Rep78 binding to multiple, different sites. The TRs are a 
complex series of palindromes and many variant structures 
can form. In this study Rep78-Rep78 recognition is directly 
demonstrated using two different assay systems, West-Western 
and chemical cross-linking analysis. These data indicate that 
Rep78-Rep78 recognition is real. Although we cannot pres-
ently estimate the maximum number of Rep78 molecules 
which are able to stably complex together, the size and num-
ber of high bands present at the highest level of DTSSP in 
Fig. 3 suggest that complexes of dimer and larger size are 
being formed. 
It has generally been found that the protein binding do-
mains are often clearly demarcated, located at either the N -
terminal or the C-terminal end for many transcriptional fac-
tors [27,34,35]. The ability of Barn-Rep to bind MBP-Rep78 
indicates that the homo-multimerization domain is fully con-
tained within the carboxy-half of Rep78. In another related 
study we demonstrate that Rep78 is also able to bind to a 
number of cellular proteins, and that most of these interac-
tions require the amino-half of Rep78 (Hermonat and Batchu, 
submitted). Thus, these data suggest that Rep78 may be able 
to simultaneously bind cellular proteins and itself. Although 
we do not have the evidence of specific biological activities for 
Rep78 multimers, it is likely that this activity is a prerequisite 
for Rep78's interaction with certain substrates. The identifica-
tion of Rep78 mutants which do not homo-multimerize or 
bind wild type will allow us to determine the significance of 
this activity. Possibly Rep78 multimerization is required for 
Rep78-cellular protein or Rep78-DNA interaction. 
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